Cytarabine
Active substance: cytarabine
INJECTION, SOLUTION · CYTARABINE 2 g/20mL
United StatesActive
Marketing holder: Meitheal Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- CYTARABINE · 2 g/20mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 11 |
|
| EU 2 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-7e31-7cc6-86e6-a89f971fc307,01a120c3-a866-7a98-afc6-09bb9fdb96cf,01a120c4-bc65-79a4-888c-98be11fe2ad0,01a120c4-c9f9-7268-abaa-9c9637395556,01a120c4-e4b7-7f67-8303-0b24644faa45;count=9 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-03bf-7b83-a55a-36a394480e68,01a1208d-ad68-7044-83fe-2fb798fc7a6d,01a1208d-ad6b-7b0d-8b29-091d3c85c22a,01a1208e-bb6c-7bf9-b320-3b56ef366626,01a12090-953e-7987-b674-6355d655b773;count=14 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 71288-109
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
- product · openFDA NDC · 71288-109 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 71288-109 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 71288-109 · Verified 2026-10-09 · open in source